Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jun 20, 2023 | 135 | TRANSCRIPT PURCHASE ORDER by Novartis Pharmaceuticals Corporation for proceedings held on 6/2/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 06/20/2023) (1) |
Jun 16, 2023 | 134 | TRANSCRIPT of Proceedings held on 6/2/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number (304) 623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 7/7/2023. Redacted Transcript Deadline set for 7/17/2023. Release of Transcript Restriction set for 9/14/2023. (rak) (Entered: 06/16/2023) (0) |
Jun 3, 2023 | 133 | Other Document Submission of Plaintiff's Closing Argument Demonstratives filed by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 06/03/2023) (30) |
Jun 2, 2023 | 131 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Oral Argument Hearing held on 6/2/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 06/02/2023) (0) |
Jun 2, 2023 | 132 | Other Document DEFENDANTS SUBMISSION OF CLOSING ARGUMENT DEMONSTRATIVES filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Ex A - Mylan Closing Argument Demonstratives)(Copland, Gordon) (Entered: 06/02/2023) (Main Document) (2) |
Jun 2, 2023 | 132 | Other Document DEFENDANTS SUBMISSION OF CLOSING ARGUMENT DEMONSTRATIVES filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit Ex A - Mylan Closing Argument Demonstratives)(Copland, Gordon) (Entered: 06/02/2023) (Exhibit Ex A - Mylan Closing Argument Demonstratives) (30) |
Jun 1, 2023 | 130 | NOTICE by Mylan Pharmaceuticals Inc. NOTICE OF SETTLEMENT IN RELATED ACTIONS REGARDING THE VALIDITY OF U.S. PATENT NOS. 8,877,938 AND 9,388,134 (Copland, Gordon) (Entered: 06/01/2023) (3) |
May 19, 2023 | 129 | Other Document Plaintiff's Reply Findings of Fact and Conclusions of Law on Mylan Pharmaceutical Inc.'s Infringement of U.S. Patent Nos. 8,877,938 and 9,388,134 filed by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 05/19/2023) (27) |
May 17, 2023 | 128 | ORDER GRANTING MOTION TO WITHDRAW 127 . Attorney Dan S. Ward terminated. Signed by Chief District Judge Thomas S Kleeh on 5/17/2023. (hrc) (Entered: 05/17/2023) (1) |
May 16, 2023 | 127 | MOTION to Withdraw as Counsel (Dan S. Ward) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/16/2023) (Main Document) (2) |
May 16, 2023 | 127 | MOTION to Withdraw as Counsel (Dan S. Ward) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/16/2023) (Proposed Order) (1) |
May 12, 2023 | 126 | TRANSCRIPT PURCHASE ORDER for proceedings held 2/27/2023 through 3/1/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 05/12/2023) (1) |
May 5, 2023 | 124 | Other Document Defendant Mylan Pharmaceuticals Inc.s Responsive Conclusions of Law Regarding Non-Infringement of the 938 and 134 Patents filed by Mylan Pharmaceuticals Inc.. (Copland, Gordon) (Entered: 05/05/2023) (30) |
May 5, 2023 | 125 | Other Document Defendant Mylan Pharmaceuticals Inc.s Proposed Findings of Fact Regarding Non-Infringement of the 938 And 134 Patents filed by Mylan Pharmaceuticals Inc.. (Copland, Gordon) (Entered: 05/05/2023) (30) |
May 1, 2023 | 123 | ORDER GRANTING 122 JOINT MOTION TO PERMIT ENTRY TO THE COURTHOUSE WITH ELECTRONIC EQUIPMENT. Signed by Chief District Judge Thomas S Kleeh on 5/1/2023. (dk) (Entered: 05/01/2023) (2) |
Apr 27, 2023 | 122 | Joint MOTION To Enter Courthouse for Hearing with Electronic Equipment by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equipment)(Law, Sandra) (Entered: 04/27/2023) (Main Document) (3) |
Apr 27, 2023 | 122 | Joint MOTION To Enter Courthouse for Hearing with Electronic Equipment by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equipment)(Law, Sandra) (Entered: 04/27/2023) (Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equ) (2) |
Apr 6, 2023 | 120 | Other Document Plaintiff's Proposed Findings of Fact filed by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 04/06/2023) (30) |
Apr 6, 2023 | 121 | Other Document Plaintiff's Opening Conclusions of Law filed by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 04/06/2023) (30) |
Mar 24, 2023 | 119 | STIPULATION AND ORDER REGARDING POST-TRIAL BRIEFING. Closing Arguments set for 6/2/2023 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 3/24/2023. (dk) (Entered: 03/24/2023) (3) |
Mar 22, 2023 | 118 | NOTICE of Change of Address by Sandra K. Law (Law, Sandra) (Entered: 03/22/2023) (2) |
Mar 14, 2023 | 117 | STIPULATION and proposed Order regarding Post-Trial Briefing by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 03/14/2023) (3) |
Mar 13, 2023 | 115 | Clerk's Witness and Exhibit List for Bench Trial held 2/27/2023 - 3/1/2023. (dk) (Entered: 03/13/2023) (0) |
Mar 13, 2023 | 116 | NOTICE OF LODGING DEFENDANT'S TRIAL DEMONSTRATIVES ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(O'Brien, William) (Entered: 03/13/2023) (Main Document) (3) |
Mar 13, 2023 | 116 | NOTICE OF LODGING DEFENDANT'S TRIAL DEMONSTRATIVES ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(O'Brien, William) (Entered: 03/13/2023) (Exhibit 1) (23) |
Mar 13, 2023 | 116 | NOTICE OF LODGING DEFENDANT'S TRIAL DEMONSTRATIVES ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(O'Brien, William) (Entered: 03/13/2023) (Exhibit 2) (4) |
Mar 13, 2023 | 116 | NOTICE OF LODGING DEFENDANT'S TRIAL DEMONSTRATIVES ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(O'Brien, William) (Entered: 03/13/2023) (Exhibit 3) (30) |
Mar 9, 2023 | 114 | Other Document Letter to Court submitting exhibits on a flash drive filed by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 03/09/2023) (1) |
Mar 2, 2023 | 109 | TRANSCRIPT of Proceedings held on 2/27/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number 304-623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 3/23/2023. Redacted Transcript Deadline set for 4/3/2023. Release of Transcript Restriction set for 5/31/2023. (rak) (Main Document 109 replaced on 3/24/2023 with corrected final transcript) (kac). (Entered: 03/02/2023) (203) |
Mar 2, 2023 | 110 | TRANSCRIPT of Proceedings held on 2/28/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number 304-623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 3/23/2023. Redacted Transcript Deadline set for 4/3/2023. Release of Transcript Restriction set for 5/31/2023. (rak) (Main Document 110 replaced on 3/24/2023 with corrected final transcript) (kac). (Entered: 03/02/2023) (187) |
Mar 2, 2023 | 111 | TRANSCRIPT of Proceedings held on 3/1/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number 304-623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 3/23/2023. Redacted Transcript Deadline set for 4/3/2023. Release of Transcript Restriction set for 5/31/2023. (rak) (Main Document 111 replaced on 3/24/2023 with corrected final transcript) (kac). (Entered: 03/02/2023) (153) |
Mar 2, 2023 | 112 | TRANSCRIPT PURCHASE ORDER by Novartis Pharmaceuticals Corporation for proceedings held on 2/27/2023 - 3/1/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 03/02/2023) (1) |
Mar 2, 2023 | 113 | TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 2/27/2023 - 3/1/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 03/02/2023) (1) |
Mar 1, 2023 | 106 | ORDER Granting 104 Motion to Seal; ***SEALED*** Signed by Chief District Judge Thomas S Kleeh on 3/1/2023. (hrc) (Entered: 03/01/2023) (0) |
Mar 1, 2023 | 108 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Bench Trial completed on 3/1/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 03/01/2023) (0) |
Feb 28, 2023 | 105 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Bench Trial - Day Two held on 2/28/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 02/28/2023) (0) |
Feb 27, 2023 | 103 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Bench Trial - Day One held on 2/27/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 02/27/2023) (0) |
Feb 24, 2023 | 101 | ORDER: the Court ADOPTS the proposed pretrial order docketed at ECF No. 87-1 as its final pretrial order in this case. Signed by Chief District Judge Thomas S Kleeh on 2/24/2023. (snc) (Entered: 02/24/2023) (1) |
Feb 24, 2023 | 102 | TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 02/17/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 02/24/2023) (2) |
Feb 22, 2023 | 98 | TRANSCRIPT of Proceedings held on 02/17/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number 304-623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 3/15/2023. Redacted Transcript Deadline set for 3/27/2023. Release of Transcript Restriction set for 5/23/2023. (rak) (Entered: 02/22/2023) (31) |
Feb 22, 2023 | 99 | TRANSCRIPT PURCHASE ORDER by Novartis Pharmaceuticals Corporation for proceedings held on 02/17/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 02/22/2023) (1) |
Feb 22, 2023 | 100 | STIPULATION AND ORDER MINIMIZING ISSUES ON WHICH TESTIMONY WILL BE PRESENTED AT TRIAL. Signed by Chief District Judge Thomas S Kleeh on 02/22/2023. (snc) (Entered: 02/22/2023) (4) |
Feb 17, 2023 | 96 | ORDER GRANTING 95 JOINT MOTION TO PERMIT ENTRY TO THE COURTHOUSE WITH ELECTRONIC EQUIPMENT filed by Novartis Pharmaceuticals Corporation. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (2) |
Feb 17, 2023 | 97 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Pretrial Conference held on 2/17/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 02/17/2023) (0) |
Feb 16, 2023 | 95 | Joint MOTION Permission to enter Courthouse with electronic equipment by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equipment)(Law, Sandra) (Entered: 02/16/2023) (Main Document) (3) |
Feb 16, 2023 | 95 | Joint MOTION Permission to enter Courthouse with electronic equipment by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equipment)(Law, Sandra) (Entered: 02/16/2023) (Proposed Order Granting Motion to Permit Entry to Courthouse with Electronic Equ) (2) |
Feb 15, 2023 | 92 | Pro Hac Vice Filing Fee for Melanie B. Dubis in the amount of $200.00 paid. Receipt Number: WVNC003605. (jb) (Entered: 02/15/2023) (0) |
Feb 15, 2023 | 93 | ORDER: granting 89 Motion for Leave to Appear pro hac vice (Melanie B. Dubis) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/15/2023. (hrc) (Entered: 02/15/2023) (1) |
Feb 15, 2023 | 94 | STIPULATION Joint Stipulation and proposed Order Minimizing Issues on which Testimony will be Presented at Trial by Novartis Pharmaceuticals Corporation. (Law, Sandra) (Entered: 02/15/2023) (5) |
Feb 14, 2023 | 90 | ORDER granting 84 Motion for Leave to Appear pro hac vice (Tasneem A. Dharamsi) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/14/2023. (hrc) (Entered: 02/14/2023) (1) |
Feb 14, 2023 | 91 | ORDER granting 85 Motion for Leave to Appear pro hac vice (Dan S. Ward) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/14/2023. (hrc) (Entered: 02/14/2023) (1) |
Feb 13, 2023 | 88 | ORDER: Pretrial Conference set for 2/17/2023 01:30 PM in Clarksburg before Chief District Judge Thomas S Kleeh with all parties appearing by Zoom. Signed by Chief District Judge Thomas S Kleeh on 2/13/2023. (hrc) (Entered: 02/13/2023) (2) |
Feb 13, 2023 | 89 | MOTION for Leave to Appear Pro Hac Vice (Melanie B. Dubis) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/13/2023) (Main Document) (3) |
Feb 13, 2023 | 89 | MOTION for Leave to Appear Pro Hac Vice (Melanie B. Dubis) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/13/2023) (Proposed Order) (1) |
Feb 10, 2023 | 87 | Joint MOTION for Hearing Requesting Pre-Trial Conference and Trial Start Date by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Attachment Proposed Joint Pre-Trial Order)(Law, Sandra) (Entered: 02/10/2023) (Main Document) (3) |
Feb 10, 2023 | 87 | Joint MOTION for Hearing Requesting Pre-Trial Conference and Trial Start Date by Novartis Pharmaceuticals Corporation. (Attachments: # 1 Attachment Proposed Joint Pre-Trial Order)(Law, Sandra) (Entered: 02/10/2023) (Attachment Proposed Joint Pre-Trial Order) (30) |
Feb 3, 2023 | 84 | MOTION for Leave to Appear Pro Hac Vice (Tasneem A. Dharamsi) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/03/2023) (Main Document) (3) |
Feb 3, 2023 | 85 | MOTION for Leave to Appear Pro Hac Vice (Dan S. Ward) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/03/2023) (Main Document) (3) |
Feb 3, 2023 | 86 | Pro Hac Vice Filing fee for Dan Ward and Tasneem Dharamsi in the amount of $400 paid. Receipt number WVNC003590. (hrc) (Entered: 02/03/2023) (0) |
Feb 3, 2023 | 84 | MOTION for Leave to Appear Pro Hac Vice (Tasneem A. Dharamsi) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/03/2023) (Proposed Order) (1) |
Feb 3, 2023 | 85 | MOTION for Leave to Appear Pro Hac Vice (Dan S. Ward) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/03/2023) (Proposed Order) (1) |
Jan 11, 2023 | 83 | STIPULATION AND ORDER ***SEALED***. Signed by Chief District Judge Thomas S Kleeh on 1/11/2023. (Emailed to Counsel) (dk) (Entered: 01/11/2023) (0) |
Dec 29, 2022 | 81 | ORDER ***SEALED***. Signed by Chief District Judge Thomas S. Kleeh on 12/29/2022. Copy emailed to counsel of record.(tlg) (Entered: 12/29/2022) (0) |
Nov 18, 2022 | 79 | ORDER. Trial set for 2/27/2023 through 3/3/2023 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh. Signed by Chief District Judge Thomas S. Kleeh on 11/18/2022. (tlg) Modified docket text on 11/18/2022 (tlg). (Entered: 11/18/2022) (1) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (Main Document) (21) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (Main Document) (7) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (Main Document) (7) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (Main Document) (8) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (Main Document) (30) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (Main Document) (1) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomis) (3) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 209 - Rule 7.1) (3) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 209 - Proposed Order) (3) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 212 - Joint Status Report) (9) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to S) (4) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic a) (6) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of D) (6) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Off) (16) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 218 - Declaration of Shannon Clark re Reply Brief) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers) (4) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 221 - Redacted Version of Letter by Novartis) (8) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 222 - Redacted Version of Declaration by Novartis) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 222 - Part 1) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 222 - Part 2) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 222 - Part 3) (30) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma) (15) |
Oct 5, 2022 | 70 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 8). MDL DN 208 - Stipulation and proposed Order to Extend Time by Novartis (Attachments: # 1 MDL DN 209 - Motion to Strike Exhibits 37-41 and related Testimony re Dr. Tomislav Friscic Deposition Redirect, # 2 MDL DN 209 - Rule 7.1, # 3 MDL DN 209 - Proposed Order, # 4 MDL DN 212 - Joint Status Report, # 5 MDL DN 214 - Stipulation to Extend Time to submit public version of Motion to Strike, # 6 MDL DN 215 - Stipulation Regarding Supplemental Expert Reports of Dr. Friscic and Dr. Rogers, # 7 MDL DN 216 - So Ordered Granting Stipulation Re Supplemental Expert Reorts of Dr. Friscic and Dr. Rogers, # 8 MDL DN 217 - Reply Brief re Motion to Preclude Defendants' Expert from Offering Opinions on Topics Outside His Expertise by Novartis, # 9 MDL DN 218 - Declaration of Shannon Clark re Reply Brief, # 10 MDL DN 219 - Redacted Version of Answering Brief in Opposition by Mylan, # 11 MDL DN 220 - Notice of Service of Supplemental Expert Report of Robin D. Rogers, Ph.D., # 12 MDL DN 221 - Redacted Version of Letter by Novartis, # 13 MDL DN 222 - Redacted Version of Declaration by Novartis, # 14 MDL DN 222 - Part 1, # 15 MDL DN 222 - Part 2, # 16 MDL DN 222 - Part 3, # 17 MDL DN 224 - Notice Pursuant to 35 USC Section 282 by Macleods Pharma, # 18 MDL DN 228 - Motion to Preclude Defendants' Reliance on Non-Prior Art Documents, MDL DN 223 Oral Order re redactions for Exhibit 2 and 3 of Joinder Letter, MDL DN 226 - Oral Order canceling Pretrial Conference, MDL DN 227 - Oral Order rescheduling Pretrial Conference for 9/1/2022.) (dk) (Entered: 10/05/2022) (MDL DN 228 - Motion to Preclue Defendants' Reliance on Non-Prior Art Docum) (16) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 248 - Redacted Version of Letter by Novartis) (4) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 249 - Redacted Version of Letter by Mylan) (4) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Porti) (3) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 251 - Suggestion of Remand Order) (2) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 252 - Redacted Version of Letter by Mylan) (3) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 253 - Redacted Version of Letter by Mylan) (5) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted ver) (6) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis) (30) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis) (30) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 257 - Conditional Remand Order) (4) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 258 - Redacted Version of Proposed Order by Novartis) (3) |
Oct 5, 2022 | 72 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 10). MDL DN 247 - Letter to Hon. Richard G. Andrews from Dominick T. Gattuso re CV of Experts. (Attachments: # 1 MDL DN 248 - Redacted Version of Letter by Novartis, # 2 MDL DN 249 - Redacted Version of Letter by Mylan, # 3 MDL DN 250 - Memorandum Order Denying Plaintiff's Motion to Preclude Portions of Dr. Fintel's Testimony, # 4 MDL DN 251 - Suggestion of Remand Order, # 5 MDL DN 252 - Redacted Version of Letter by Mylan, # 6 MDL DN 253 - Redacted Version of Letter by Mylan, # 7 MDL DN 254 - Stipulation and proposed Order to Extend Time to file redacted versions of proposed Joint Pretrial Order, Revised Proposed Joint Pretrial Order, Suggestion of Remand Proposed Order, # 8 MDL DN 255 - Redacted Version of Proposed Pretrial Order by Novartis, # 9 MDL DN 256 - Redacted Version of Proposed Pretrial Order by Novartis, # 10 MDL DN 257 - Conditional Remand Order, # 11 MDL DN 258 - Redacted Version of Proposed Order by Novartis) (dk) (Additional attachment(s) added on 10/5/2022: # 12 MDL DN 259 - Stipulation Designating Record on Remand) (dk). (Entered: 10/05/2022) (MDL DN 259 - Stipulation Designating Record on Remand) (3) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 234 - Redacted Version of Letter by Novartis) (10) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's) (17) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 241 - Redacted Version of Appendix by Novartis) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Redacted Version of Appendix by Novartis) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 1) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 2) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 3) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 4) (12) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 5) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 6) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 7) (26) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 8) (29) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 242 - Part 9) (30) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 244 - Order after Pretrial Conference) (2) |
Oct 5, 2022 | 71 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 9). MDL DN 233 - Letter to Hon. Richard G. Andrews from Daniel Silver re Proposed Order Setting Schedule for Trial. (Attachments: # 1 MDL DN 234 - Redacted Version of Letter by Novartis, # 2 MDL DN 240 - Redacted Version of Motion in Limine to Preclude Dr. Steed's Written Description Opinions, # 3 MDL DN 241 - Redacted Version of Appendix by Novartis, # 4 MDL DN 242 - Redacted Version of Appendix by Novartis, # 5 MDL DN 242 - Part 1, # 6 MDL DN 242 - Part 2, # 7 MDL DN 242 - Part 3, # 8 MDL DN 242 - Part 4, # 9 MDL DN 242 - Part 5, # 10 MDL DN 242 - Part 6, # 11 MDL DN 242 - Part 7, # 12 MDL DN 242 - Part 8, # 13 MDL DN 242 - Part 9, # 14 MDL DN 244 - Order after Pretrial Conference, # 15 MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for experts) (dk) (Entered: 10/05/2022) (MDL DN 245 - Letter to Hon. Richard G. Andrews from Daniel Silver re CV for exp) (30) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020) (30) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 209 - Notice of Service of Defendants' Objections and Responses to) (2) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defe) (1) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Reques) (4) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 261 - Oral Order re discovery dispute) (1) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Sample) (11) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews) (1) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 577 - Redacted Version of Stipulation by Novartis) (3) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D.) (5) |
Oct 5, 2022 | 77 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-MD-02930 FROM THE DISTRICT OF DELAWARE. MDL DN 75 - Oral Order. (Attachments: # 1 MDL DN 76 - Official Transcript of Telephone Conference held 8/24/2020, # 2 MDL DN 209 - Notice of Service of Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories, # 3 MDL DN 241 - Letter to Hon. Leonard P. Stark from John C. Phillips, Jr. re Defendants' Technology Tutorial, # 4 MDL DN 260 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Request for Discovery Hearing, # 5 MDL DN 261 - Oral Order re discovery dispute, # 6 MDL DN 263 - Letter to Hon. Leonard P. Stark from Dominick T. Gattuso re Samples, # 7 MDL DN 511 - Order Reassigning Litigation to Hon. Richard G. Andrews, # 8 MDL DN 577 - Redacted Version of Stipulation by Novartis, # 9 MDL DN 622 - Motion to Strike Expert Reports of Robin D. Rogers, Ph.D., # 10 MDL DN 673 - Oral Order re Motion to Strike Expert Reports, MDL DN 257 - Oral Order re 6/8/2021 Claim Construction Hearing, MDL DN 259 - Oral Order re 6/8/2021 Markman Hearing available to the public, MDL DN 513 - Oral Order re filing of joint status report.) (dk) (Entered: 10/05/2022) (MDL DN 673 - Oral Order re Motion to Strike Expert Reports) (1) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22) (3) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D.) (8) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D.) (3) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D.) (11) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint stat) (7) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions) (2) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D.) (5) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 199 - Stipulation to Extend Time to file redactions) (2) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 200 - Redacted Version of Letter by Novartis) (8) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 201 - Redacted Version of Declaration by Novartis) (30) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D.) (4) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 203 - Redacted Version of Letter by Mylan) (3) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 203 - Exhibits 1-11) (30) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu . Palapura re redacte) (1) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan) (2) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Top) (9) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 206 - 7.1 Certification) (1) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 206 - Proposed Order) (4) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel) (4) |
Oct 5, 2022 | 69 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 7). MDL DN 188 - Stipulation and proposed Order Extending Time for Close of Expert Discovery. (Attachments: # 1 MDL DN 189 - Letter to Hon. Richard G. Andrews from Daniel M. Silver re 6/3/22 Oral Order, # 2 MDL DN 190 - Notice to Take Deposition of Alexander M. Klibanov, Ph.D., # 3 MDL DN 191 - Notice to Take Deposition of Hatem Titi, Ph.D., # 4 MDL DN 193 - Notice to Take Deposition of Dr. Gregory Bell, Ph.D., # 5 MDL DN 196 - Stipulation and proposed Order to Extend Time to submit joint status report, # 6 MDL DN 197 - Stipulation and proposed Order to Extend Time to File redactions, # 7 MDL DN 198 - Notice to Take Deposition of Robin D. Rogers, Ph.D., # 8 MDL DN 199 - Stipulation to Extend Time to file redactions, # 9 MDL DN 200 - Redacted Version of Letter by Novartis, # 10 MDL DN 201 - Redacted Version of Declaration by Novartis, # 11 MDL DN 202 - Notice to Take Deposition of Tomislav Friscic, Ph.D., # 12 MDL DN 203 - Redacted Version of Letter by Mylan, # 13 MDL DN 203 - Exhibits 1-11, # 14 MDL DN 204 - Letter to Hon. Richard G. Andrews from Bindu. Palapura re redacted filing, # 15 MDL DN 205 - Declaration of Preston Imperatore re Letter by Mylan, # 16 MDL DN 206 - Motion to Preclude Expert Dr. Fintel from Offering Opinions on Topics Outside his Expertise, # 17 MDL DN 206 - 7.1 Certification, # 18 MDL DN 206 - Proposed Order, # 19 MDL DN 207 - Declaration of Shannon K. Clark re Motion to Preclude Dr. Fintel, # 20 MDL DN 207 - Exhibits A-H, MDL DN 192 - Oral Order setting hearing on Motion and Joinders to Strike) (dk) (Entered: 10/05/2022) (MDL DN 207 - Exhibits A-H) (30) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 148 - Notice to Take Deposition of Michael Exton) (8) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 156 - Certification) (1) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 159 - Redacted Version of Status Report) (17) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 160 - Redacted Version of Stipulation) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D.) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinal) (17) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trou) (9) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews) (1) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 168 - Joint Status Report) (17) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Exper) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D.) (3) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.) (5) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale) (12) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. K) (11) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding ca) (1) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. A) (11) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D.) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzge) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D.) (8) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Roger) (4) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D.) (5) |
Oct 5, 2022 | 68 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 6). MDL DN 147 - Notice of Service of Novartis's Notice of Deposition; and Discovery Requests-Responses. (Attachments: # 1 MDL DN 148 - Notice to Take Deposition of Michael Exton, # 2 MDL DN 156 - Motion for PHV Appearance of Whitney Meier Howard, # 3 MDL DN 156 - Certification, # 4 MDL DN 159 - Redacted Version of Status Report, # 5 MDL DN 160 - Redacted Version of Stipulation, # 6 MDL DN 161 - Notice of Service of Expert Report of Dr. Jonathan W. Steed, # 7 MDL DN 162 - Notice of Service of Opening Expert Report of Dan Fintel, M.D., # 8 MDL DN 163 - Notice of Service of Opening Expert Report of Laird Forrest, # 9 MDL DN 164 - Notice of Service of Responsive Expert Report of Francis G. Spinale, M.D., Ph.D.; Responsive Expert Report of Dr. Alexander M. Klibanov; Expert Report of Gregory K. Bell, Ph.D., # 10 MDL DN 165 - Notice of Service of Responsive Expert Report of Bernhardt L. Trout, Ph.D, # 11 MDL DN 166 - Order Reassigning Case to Judge Richard G. Andrews, # 12 MDL DN 168 - Joint Status Report, # 13 MDL DN 169 - Stipulation and proposed Order to Extend Time to Serve Reply Expert Reports, # 14 MDL DN 170 - Notice of Service of Reply Expert Report of Dr. Jonathan W. Steed, # 15 MDL DN 171 - Notice of Service of Reply Expert Report of Dan Fintel, M.D., # 16 MDL DN 172 - Notice of Service of Reply Expert Report of Adam J. Matzger, Ph.D.; Reply Expert Report of Robin D. Rogers, P.D., # 17 MDL DN 174 - Notice of Service of Sur-Reply Expert Report of Francis G. Spinale, M.D., Ph.D., # 18 MDL DN 175 - Notice of Service of Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 19 MDL DN 176 - Letter to Hon. Richard G. Andrews from David E. Moore regarding case status, # 20 MDL DN 177 - Notice of Service of Supplemental Sur-Reply Expert Report of Dr. Alexander M. Klibanov, # 21 MDL DN 178 - Notice ot Take Deposition of Ivan T. Hofmann, # 22 MDL DN 179 - Notice to Take Deposition of Dr. Laird Forrest, # 23 MDL DN 180 - Notice to Take Deposition of Dan Fintel, M.D., # 24 MDL DN 181 - Notice of Service of Sur-Sur-Reply Expert Report of Adam J. Matzger, Ph.D., # 25 MDL DN 182 - Notice to Take Deposition of Bernhardt L. Trout, Ph.D., # 26 MDL DN 183 - Notice of Service of Sur-Sur-Reply Expert Report of Robin D. Rogers, Ph.D., # 27 MDL DN 185 - Notice of Defendants' Deposition of Adam J. Matzger, Ph.D., # 28 MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed, MDL DN 167 Oral Order requiring filing of status report, MDL DN 173 Oral Order rescheduling status/scheduling conference, MDL DN 184 Oral Order re 30-month Stay) (dk) (Entered: 10/05/2022) (MDL DN 186 - Notice to Take Deposition of Dr. Jonathan W. Steed) (4) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (Main Document) (30) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (Main Document) (26) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (Main Document) (15) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (Main Document) (6) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (Main Document) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff') (5) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL 118 - Joint Claim Construction Brief filed by Novartis) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 119 - Appendix re Joint Claim Construction Brief) (16) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 119 - Exhibits A-D) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Appendix re Joint Claim Construction Brief) (16) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Exhibits 1-29) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Exhibits 35-43) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Exhibit 44) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Exhibits 45-57) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 120 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re) (2) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim) (2) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispu) (3) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 125 - Exhibit A) (30) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 127 -Amended Complaint) (14) |
Oct 4, 2022 | 66 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 4). MDL DN 116 - Statement re Novartis's Comments on Defendants' Technology Tutorial. (Attachments: # 1 MDL DN 117 - Notice of Service of Defendants' Objection to Plaintiff's Notice of Deposition of Raymond Butcher, Ph.D., # 2 MDL 118 - Joint Claim Construction Brief filed by Novartis, # 3 MDL DN 119 - Appendix re Joint Claim Construction Brief, # 4 MDL DN 119 - Exhibits A-D, # 5 MDL DN 120 - Appendix re Joint Claim Construction Brief, # 6 MDL DN 120 - Exhibits 1-29, # 7 MDL DN 120 - Exhibits 35-43, # 8 MDL DN 120 - Exhibit 44, # 9 MDL DN 120 - Exhibits 45-57, # 10 MDL DN 121 - Letter to Hon. Chief Judge Leonard P. Start from Daniel Silver re claim construction hearing, # 11 MDL DN 123 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re claim construction hearing, # 12 MDL DN 125 - Letter to Chief Judge Leonard P. Stark from Daniel Silver re dispute letter, # 13 MDL DN 125 - Exhibit A, # 14 MDL DN 127 -Amended Complaint, # 15 MDL DN 127 - Exhibits A-D; MDL DN 122 Oral Order scheduling claim construction hearing for 6/8/2021; MDL 124 Oral Order providing public access to 6/8/21 Markman hearing; MDL 126 Oral Order advising of procedure for ADR) (dk) (Entered: 10/04/2022) (MDL DN 127 - Exhibits A-D) (30) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 50 - Notice to Counsel) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 51 - Notice of Appearance - David Moore) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 53 - Notice of Appearance by Tracey E. Timlin) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 54 - Notice of Appearance by Daniel M. Silver) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 55 - Notice of Appearance by Alexandra M. Joyce) (1) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 56 - Motion for PHV of Nichols Kallas) (5) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 57 - Answer to Complaint, Counterclaim by Novartis) (16) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi) (3) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 59 - Notice of Service of Defendant's Initial Disclosures) (2) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 60 - Notice of Service of Mylan's Core Technical Documents) (2) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures) (13) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order) (11) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 64 - Joint Letter to Hon. Leonard P. Stark) (30) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 65 - Joint Letter to Hon. Leonard P. Stark) (30) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants) (19) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 68 - Proposed Stipulated Protective Order) (30) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 69 - Notice of Service re 8/24/2020 Oral Order) (2) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 70 - Notice of Service) (19) |
Oct 4, 2022 | 63 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 1). (Attachments: # 1 MDL DN 50 - Notice to Counsel, # 2 MDL DN 51 - Notice of Appearance - David Moore, # 3 MDL DN 52 - Notice of Appearance - Bindu Ann George Palapura, # 4 MDL DN 53 - Notice of Appearance by Tracey E. Timlin, # 5 MDL DN 54 - Notice of Appearance by Daniel M. Silver, # 6 MDL DN 55 - Notice of Appearance by Alexandra M. Joyce, # 7 MDL DN 56 - Motion for PHV of Nichols Kallas, # 8 MDL DN 57 - Answer to Complaint, Counterclaim by Novartis, # 9 MDL DN 58 - Motion for PHV of Tasneem A. Dharamsi, # 10 MDL DN 59 - Notice of Service of Defendant's Initial Disclosures, # 11 MDL DN 60 - Notice of Service of Mylan's Core Technical Documents, # 12 MDL DN 61 - Notice of Service of Plaintiff's Initial Disclosures, # 13 MDL DN 63 - Stipulation to Extend Time to Submit Proposed Scheduling Order, # 14 MDL DN 64 - Joint Letter to Hon. Leonard P. Stark, # 15 MDL DN 65 - Joint Letter to Hon. Leonard P. Stark, # 16 MDL DN 67 - Notice of Service of Novartis's First Set of RFP to Defendants, # 17 MDL DN 68 - Proposed Stipulated Protective Order, # 18 MDL DN 69 - Notice of Service re 8/24/2020 Oral Order, # 19 MDL DN 70 - Notice of Service, # 20 MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Order; MDL DN 62 - Oral Order setting Scheduling and Discovery Conference; MDL 66 - Oral Order ordering revised protective order and revised proposed scheduling order) (dk) (Entered: 10/04/2022) (MDL DN 71 - Stipulation to Extend Time to submit revised proposed Scheduling Or) (10) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for) (5) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 74 - Scheduling Order) (24) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories t) (17) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novar) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novar) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Pla) (5) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 79 - Notice of Service of Novartis's Objections and Responses to De) (14) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories) (20) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 81 - Notice of Service of Mylans Responses and Objections to Novartis) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 82 - Notice of Service of Novartis's Objections and Responses to De) (13) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novar) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 84 - Amended Disclosure Statement by Mylan) (1) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (Notice of Service of Defendants' Joint Initial Invalidity Contentions) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin) (1) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructio) (6) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 89 - Notice of Change of Address of Certain PHV Counsel) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First) (5) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections) (14) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 92 - Stipulation to Extend Time for completion of production of document) (12) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interroga) (2) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Construction) (15) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Constr) (11) |
Oct 4, 2022 | 64 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE 1:20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 2). MDL DN 72 - Proposed Scheduling Order. (Attachments: # 1 MDL DN 73 - Notice of Service Defendant's First Set of Joint Requests for RFP, # 2 MDL DN 74 - Scheduling Order, # 3 MDL DN 75 - Notice of Service of Novartis's First Set of Interrogatories to Defendants, # 4 MDL DN 76 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of RFP, # 5 MDL DN 77 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of RFP, # 6 MDL DN 78 - Notice of Service of Defendants First Set of Interrogatories to Plaintiff, # 7 MDL DN 79 - Notice of Service of Novartis's Objections and Responses to Defendants' First Set of Joint Requests for RfP, # 8 MDL DN 80 - Notice of Service of Novartis's Second Set of Interrogatories to Defendants, # 9 MDL DN 81 - Notice of Service of Mylan's Responses and Objections to Novartis's First Set of Interrogatories, # 10 MDL DN 82 - Notice of Service of Novartis's Objections and Responses to Defendants First Set of Interrogatories, # 11 MDL DN 83 - Notice of Service of Mylan's Responses and Objections to Novartis's Second Set of Interrogatories, # 12 MDL DN 84 - Amended Disclosure Statement by Mylan, # 13 MDL DN 85 - Notice of Service of Defendants' Joint Initial Invalidity Contentions, # 14 MDL DN 86 - Notice of Withdrawal of Tracey E. Timlin, # 15 MDL DN 87 - Notice of Service of Defendants' Preliminary Claim Constructions and Supporting Evidence by Dr. Reddy Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals, Inc., # 16 MDL DN 88 - Notice of Service of Mylan's First Supplemental Responses and Objections to Novartis's Second Set of Interrogatories, # 17 MDL DN 89 - Notice of Change of Address of Certain PHV Counsel, # 18 MDL DN 90 - Notice of Service of Defendant Crystal Pharmaceutical's First Set of Individual Interrogatories to Plaintiff, # 19 MDL DN 91 - Notice of Service of Novartis's First Supplemental Objections and Responses to First Set of Interrogatories, # 20 MDL DN 92 - Stipulation to Extend Time for completion of production of documents, # 21 MDL DN 93 - Notice of Service of Mylan's First Set of Individual Interrogatories to Novartis, # 22 MDL DN 94 - Notice of Service of Novartis's Rebuttal Proposed Constructions of Claim Terms and Intrinsic Evidence, # 23 MDL DN 95 - Stipulation to Extend Time for Parties to Submit Joint Claim Construction Chart, # 24 MDL DN 96 - Claim Construction Chart) (dk) (Entered: 10/04/2022) (MDL DN 96 - Claim Construction Chart) (23) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclai) (27) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 130 - Answer to Counterclaim by Novartis) (16) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objection) (15) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringem) (20) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp.) (19) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 134 - Notice to Take Deposition of Randy Lee Webb) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individua) (5) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 136 - Notice to Take Deposition of Yugang Liu) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 138 - Notice to Take Deposition of Paul Sutton) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 139 - Notice to Take Deposition of Bin Hu) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 140 - Notice to Take Deposition of Lili Feng) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 141 - Notice to Take Deposition of Mahavir Prashad) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 142 - Notice to Take Deposition of Michael J. Girgis) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 143 - Notice to Take Deposition of Piotr Karpinski) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidit) (5) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 146 - Notice of Service of Novartis's Objections and Responses to D) (19) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Nova) (2) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 150 - Notice of Service of Discovery Responses by Novartis) (19) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response) (14) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 152 - Notice to Take Deposition of Michael Motto) (11) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objectio) (2) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 154 - Notice of Service of Novartis's Objections and Responses to D) (18) |
Oct 4, 2022 | 67 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 5). MDL DN 128 - Office Transcript of Claim Construction Hearing held 6/8/2021. (Attachments: # 1 MDL DN 129 - Answer to Amended Complaint, Affirmative Defenses, and Counterclaim against Novartis, # 2 MDL DN 130 - Answer to Counterclaim by Novartis, # 3 MDL DN 131 - Notice of Service of Novartis's Second Supplemental Objections and Responses to Defendants' First Set of Interrogatories, # 4 MDL DN 132 - Notice of Service of Plaintiff's First Supplemental Infringement Contentions Against Defendant; First Supplemental Objections and Responses to Defendant's First Set of Individual Interrogatories, # 5 MDL DN 133 - Notice to Take Deposition of Novartis Pharmaceuticals Corp., # 6 MDL DN 134 - Notice to Take Deposition of Randy Lee Webb, # 7 MDL DN 135 - Notice of Service of Crystal Pharma's Second Set of Individual Interrogatories to Plaintiff, # 8 MDL DN 136 - Notice to Take Deposition of Yugang Liu, # 9 MDL DN 137 - Notice to Take Deposition of Sven Erik Godtfredsen, # 10 MDL DN 138 - Notice to Take Deposition of Paul Sutton, # 11 MDL DN 139 - Notice to Take Deposition of Bin Hu, # 12 MDL DN 140 - Notice to Take Deposition of Lili Feng, # 13 MDL DN 141 - Notice to Take Deposition of Mahavir Prashad, # 14 MDL DN 142 - Notice to Take Deposition of Michael J. Girgis, # 15 MDL DN 143 - Notice to Take Deposition of Piotr Karpinski, # 16 MDL DN 144 - Notice to Take Deposition of Thomas J. Blacklock, # 17 MDL DN 145 - Notice of Service of Defendants' Supplemental Joint Invalidity Contentions, # 18 MDL DN 146 - Notice of Service of Novartis's Objections and Responses to Defendants' Notice of Deposition to Plaintiff and Plaintiff's Second Supplemental Infringement Contentions Against Defendants, # 19 MDL DN 149 - Notice of Service of Mylan's Responses and Objections to Novartis's Notice of Deposition, # 20 MDL DN 150 - Notice of Service of Discovery Responses by Novartis, # 21 MDL DN 151 - Notice of Service of Novartis's Second Supplemental Response to Defendants' Interrogatory No. 3, # 22 MDL DN 152 - Notice to Take Deposition of Michael Motto, # 23 MDL DN 153 - Notice of Service of Mylan's Discovery Responses and Objections, # 24 MDL DN 154 - Notice of Service of Novartis's Objections and Responses to Discovery Requests, # 25 MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Report) (dk) (Entered: 10/04/2022) (MDL DN 155 - Stipulation to Extend Deadline for Submission of Joint Status Repo) (12) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 97 - Exhibits 1-17) (30) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 97 - Exhibits 18-25) (30) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 97 - Exhibits 26-36) (30) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel) (2) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 99 - Stipulation to Extend Time for substantial completion of document p) (12) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 100 - Notice of Service of Novartis's Objections and Responses to F) (2) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Br) (14) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer r) (12) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Ple) (12) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D.) (11) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Const) (4) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled) (2) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 107 -Notice of Service of Novartis's Objections to Defendants') (15) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brie) (16) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel) (1) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver) (1) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D.) (5) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pl) (13) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Constr) (4) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended C) (13) |
Oct 4, 2022 | 65 | JOINTLY DESIGNATED RECORDS FOR MDL REMAND RE: 1-20-CV-445 FROM THE DISTRICT OF DELAWARE (Part 3). MDL DN 97 - Appendix. (Attachments: # 1 MDL DN 97 - Exhibits 1-17, # 2 MDL DN 97 - Exhibits 18-25, # 3 MDL DN 97 - Exhibits 26-36, # 4 MDL DN 98 - Notice requesting Clerk to remove Michael L. Binns as co-counsel, # 5 MDL DN 99 - Stipulation to Extend Time for substantial completion of document production, # 6 MDL DN 100 - Notice of Service of Novartis's Objections and Responses to First of of Individual Interrogatories, # 7 MDL DN 101 - Notice of Service of Novartis's Opening Claim Construction Brief, # 8 MDL DN 102 - Stipulation and proposed Order Extending Time to Meet and Confer re Depositions, # 9 MDL DN 103 - Stipulation and proposed Order Extending Deadline to Amend the Pleadings, # 10 MDL DN 104 - Notice to Take Deposition of Alexander Klibanov, Ph.D., # 11 MDL DN 105 - Notice of Service of Defendants' Joint Responsive Claim Construction Brief, # 12 MDL DN 106 - Notice of Service of Mylan's Production of Documents Labeled Mylan_Sacval_00061802-Mylan_Sacval_00158295, # 13 MDL DN 107 -Notice of Service of Novartis's Objections to Defendants' Notice of Deposition of Alexander Klibanov, Ph.D., # 14 MDL DN 108 - Notice of Service of Novartis's Reply Claim Construction Brief, # 15 MDL DN 109 - Notice request Clerk to remove Karen L. Carroll as co-counsel, # 16 MDL DN 110 - Letter to Hon. Chief Judge Leonard P. Stark from Daniel M. Silver re Plaintiff's Technology Tutorial, # 17 MDL DN 111 - Notice of Deposition of Raymond Butcher, Ph.D., # 18 MDL DN 112 - Stipulation to Extend Time for Plaintiff to Amend or Supplement Pleadings, # 19 MDL DN 114 - Notice of Service of Defendants' Joint Sur-Reply Claim Construction Brief, # 20 MDL DN 115 - Stipulation and proposed Order Regarding Novartis's Amended Complaints, # 21 MDL DN 115 - Exhibits A-N. MDL DN 113 - Oral Order setting Claim Construction Hearing for 6/8/2021.) (dk) (Entered: 10/04/2022) (MDL DN 115 - Exhibits A-N) (30) |
Sep 30, 2022 | 62 | Courtesy Copy of Stipulation Designating Record on Remand. (dk) (Entered: 09/30/2022) (3) |
Sep 22, 2022 | 60 | COPY OF JPML CONDITIONAL REMAND ORDER FINALIZED (re: pldg. ( 87 in MDL No. 2930, 52 in WVN/1:19-cv-00201) ) - 1 action(s) - Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/22/2022. (Attachments: # 1 Other Suggestion of Remand) Associated Cases: MDL No. 2930, WVN/1:19-cv-00201. (Attachments: # 1 Suggestion of Remand) (dk) (Entered: 09/22/2022) (Main Document) (2) |
Sep 22, 2022 | 60 | COPY OF JPML CONDITIONAL REMAND ORDER FINALIZED (re: pldg. ( 87 in MDL No. 2930, 52 in WVN/1:19-cv-00201) ) - 1 action(s) - Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/22/2022. (Attachments: # 1 Other Suggestion of Remand) Associated Cases: MDL No. 2930, WVN/1:19-cv-00201. (Attachments: # 1 Suggestion of Remand) (dk) (Entered: 09/22/2022) (Suggestion of Remand) (2) |
Sep 20, 2022 | 59 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Status Conference held on 9/20/2022. (Court Reporter FTR Tape# CBG Kleeh Novartis Pharmaceuticals v Mylan Pharmaceuticals 1-19cv201 and 1-21cv146 09202022.) (dk) (Entered: 09/20/2022) (0) |
Sep 16, 2022 | 58 | ORDER GRANTING 56 MOTION TO RESCHEDULE JOINT STATUS CONFERENCE. The Court GRANTS the motion and RESCHEDULES the status conference, jointly with Civil Action No. 1:21-CV-146, to September 20, 2022, at 2:00 p.m, via Zoom videoconferencing, before Chief District Judge Thomas S. Kleeh. Signed by Chief District Judge Thomas S Kleeh on 9/16/2022. (dk) (Entered: 09/16/2022) (2) |
Sep 14, 2022 | 56 | MOTION Reschedule Joint Status Conference re 55 Order, Set/Reset Hearings by Novartis Pharmaceuticals Corporation. (Companion, James) (Entered: 09/14/2022) (2) |
Sep 14, 2022 | 57 | RESPONSE to Motion re 56 MOTION Reschedule Joint Status Conference re 55 Order, Set/Reset Hearings filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 09/14/2022) (3) |
Sep 12, 2022 | 55 | ORDER SCHEDULING JOINT STATUS CONFERENCE ( Status Conference set for 10/11/2022 02:30 PM via Zoom before Chief District Judge Thomas S Kleeh.) Signed by Chief District Judge Thomas S Kleeh on 9/12/2022. (jb) (Entered: 09/12/2022) (2) |
Sep 9, 2022 | 54 | Courtesy Copy of Suggestion of Remand Order re MDL 20-2930-RGA. Signed by District Judge Richard G. Andrews of the District of Delaware on the 9th day of September, 2022. (kac) (Entered: 09/09/2022) (2) |
Sep 16, 2021 | 53 | Order Reassigning Case (1) Docket Text:ORDER TRANSFERRING CASE. Case reassigned to District Judge Thomas S. Kleeh for all further proceedings. Senior Judge Irene M. Keeley no longer assigned to case. Signed by Senior Judge Irene M. Keeley on 9/16/2021. (dk) |
May 6, 2021 | 51 | Main Document (3) Docket Text: MOTION to Withdraw as Attorney (Karen L. Carroll) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
May 6, 2021 | 51 | Proposed Order (1) |
May 6, 2021 | 52 | Order on Motion to Withdraw as Attorney (1) Docket Text:ORDER GRANTING [51] MOTION TO WITHDRAW. The Court GRANTS the motion and DIRECTS the Clerk to terminate Attorney Karen L. Carroll from the list of attorneys in this case. Signed by Senior Judge Irene M. Keeley on 5/6/2021. (wrr) |
Mar 3, 2021 | 50 | Order on Motion to Withdraw as Attorney (1) Docket Text:ORDER GRANTING MOTION TO WITHDRAW [DKT. NO. [49]]. The Court GRANTS Defendant Mylan Pharmaceuticals Inc.'s motion for leave for Micheal Binns, one of its attorneys, to withdraw as counsel in this matter. Signed by Senior Judge Irene M. Keeley on 3/3/2021. (wrr) Modified on 3/3/2021 to correct docket text (wrr). NEF regenerated. |
Feb 26, 2021 | 49 | Motion to Withdraw as Attorney (3) Docket Text: MOTION to Withdraw as Attorney (Micheal L. Binns) by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Jul 9, 2020 | 43 | Motion for Leave to Appear (4) |
Jul 9, 2020 | 42 | Motion for Leave to Appear (4) |
Jul 9, 2020 | 41 | Motion for Leave to Appear (4) |
Jul 9, 2020 | 14 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 13 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 12 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 11 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 10 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 9 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 8 | Motion for Leave to Appear (2) |
Jul 9, 2020 | 7 | Motion for Leave to Appear (2) |
Mar 31, 2020 | N/A | Case Transfer Complete (0) Docket Text: Case Transfer Complete - Case transferred to District of Delaware on 3/31/2020. District of Delaware's case number is 1:20md00445. (dk) |
Mar 30, 2020 | N/A | Case Transferred Out to Another District (0) Docket Text: Case transferred to District of Delawarere MDL 2930. Entire Case file electronically transmitted. (wrr) Modified on 3/30/2020 to correct docket text (wrr). NEF regenerated. |
Mar 30, 2020 | 48 | Other Document (4) Docket Text: CERTIFIED COPY OF JPML TRANSFER ORDER re: pldg. ([1] in MDL No. 2930) Transferring 1 action(s) to Judge Judge Leonard P. Stark in the D. Delaware. Signed by Judge Ellen Segal Huvelle, Acting Chair, PANEL ON MULTIDISTRICT LITIGATION, on 3/27/2020. Associated Cases: MDL No. 2930, DE/1:19-cv-01979, DE/1:19-cv-02021, DE/1:19-cv-02053, WVN/1:19-cv-00201. (wrr) |
Mar 16, 2020 | 41 | Proposed Order (1) |
Mar 16, 2020 | 42 | Proposed Order (1) |
Mar 16, 2020 | 43 | Proposed Order (1) |
Mar 16, 2020 | 45 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [43] Motion for Leave to Appear Pro Hac Vice for Attorney Michael L. Binns. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) |
Mar 16, 2020 | 46 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [41] Motion for Leave to Appear Pro Hac Vice for attorney Karen L. Carroll. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) |
Mar 16, 2020 | 47 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [42] Motion for Leave to Appear Pro Hac Vice for Attorney Robert L. Florence. Signed by Senior Judge Irene M. Keeley on 3/16/2020. (Copy counsel of record)(jmm) |
Mar 16, 2020 | 41 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Karen L. Carroll) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 16, 2020 | 42 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Robert L. Florence) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 16, 2020 | 43 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Micheal L. Binns) by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
Mar 12, 2020 | 39 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, AFFIRMATIVE DEFENSES, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Mylan Pharmaceuticals Inc..(O'Brien, William) |
Mar 12, 2020 | 40 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals Inc... (O'Brien, William) |
Feb 5, 2020 | 37 | Stipulation (4) Docket Text: STIPULATION AND ORDER by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Feb 5, 2020 | 38 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER. It is stipulated between the parties that Plaintiff dismisses its claims against Mylan Inc. and Mylan Laboratories Limited in this action. Signed by Senior Judge Irene M. Keeley on 2/5/2020. (wrr) |
Jan 24, 2020 | 36 | Order on Motion for Miscellaneous Relief (2) Docket Text: ORDER GRANTING PLAINTIFF'S MOTION TO EXTEND CASE SCHEDULE [DKT. NO. [30]]. The Court GRANTS Novartis's motion (Dkt. No. [30]) and EXTENDS the current dates and deadlines as follows: Mylan to answer, move, or otherwise respond to Novartis's complaint on or before April 6, 2020; Rule 26 Meeting to be held by 4/20/2020; Rule 26 Meeting Report due by 5/1/2020; Scheduling Conference set for 5/15/2020 12:15 PM, by telephone; Discovery due by 5/22/2020. Signed by Senior Judge Irene M. Keeley on 1/24/2020. (wrr) |
Jan 23, 2020 | 35 | Response to Motion (3) Docket Text: RESPONSE to Motion re [30] MOTION Extend the Current Scheduled Dates in this Case by 60 Days (non-Opposition by Mylan) filed by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
Jan 17, 2020 | 34 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER FOR EXTENSION OF TIME TO RESPOND TO PLAINTIFF'S [30] MOTION TO EXTEND CURRENT CASE SCHEDULE AND SECOND STIPULATION FOR EXTENSION OF TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO COMPLAINT. By agreement of the parties, the deadline for Mylan to respond to Plaintiff's motion will be extended from January 16, 2020 through and including January 23, 2020, the deadline for Plaintiff to reply to Mylan's response to Plaintiff's motion will be extended from January 23, 2020 through and including January 30, 2020, and the deadline for Mylan to answer, move, or otherwise respond to the Complaint will be extended from January 21, 2020 through and including February 6, 2020. Signed by Senior Judge Irene M. Keeley on 1/17/2020. (wrr) |
Jan 16, 2020 | 33 | Stipulation (3) Docket Text: STIPULATION AND ORDER FOR EXTENSION OF TIME TO RESPOND TO PLAINTIFF'S MOTION TO EXTEND CURRENT CASE SCHEDULE AND SECOND STIPULATION FOR EXTENSION OF TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO COMPLAINT by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Jan 3, 2020 | 32 | Stipulation (2) Docket Text: STIPULATION For Extension of Time to Answer, Move or Otherwise Response to Complaint by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William) |
Jan 2, 2020 | 30 | Motion for Miscellaneous Relief (4) Docket Text: MOTION Extend the Current Scheduled Dates in this Case by 60 Days by Novartis Pharmaceuticals Corporation. (Companion, James) |
Jan 2, 2020 | 31 | MEMORANDUM (15) Docket Text: MEMORANDUM in Support by Novartis Pharmaceuticals Corporation re [30] MOTION Extend the Current Scheduled Dates in this Case by 60 Days . (Companion, James) |
Dec 20, 2019 | 29 | Other Document (8) |
Dec 20, 2019 | 29 | Attachment (11) |
Dec 20, 2019 | 29 | Attachment (3) |
Dec 20, 2019 | 29 | Attachment (2) |
Dec 20, 2019 | 29 | Attachment (3) |
Dec 20, 2019 | 29 | Attachment (12) |
Dec 20, 2019 | 29 | Attachment (101) |
Dec 20, 2019 | 29 | Attachment (35) |
Dec 20, 2019 | 29 | Attachment (70) |
Dec 20, 2019 | 29 | Attachment (22) |
Dec 20, 2019 | 29 | Main Document (8) Docket Text: Courtesy Copy of Motion to Transfer filed with the JDML. (Attachments: # (1) Attachment, # (2) Attachment, # (3) Attachment, # (4) Attachment, # (5) Attachment, # (6) Attachment, # (7) Attachment, # (8) Attachment, # (9) Attachment)(mh) |
Dec 16, 2019 | 28 | FirstOrder (3) Docket Text: FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 2/4/2020. Rule 26 Meeting Report due by 2/18/2020. Scheduling Conference set for 3/3/2020, at 1:30 PM, in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 3/10/2020. Signed by Senior Judge Irene M. Keeley on 12/16/2019. (dk) |
Dec 15, 2019 | 27 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by William J O'Brien on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. (O'Brien, William) |
Dec 12, 2019 | 24 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Pharmaceuticals Inc. waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) |
Dec 12, 2019 | 25 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Inc. waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) |
Dec 12, 2019 | 26 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Novartis Pharmaceuticals Corporation. Mylan Laboratories Limited waiver sent on 11/15/2019, answer due 1/14/2020. (Companion, James) |
Nov 6, 2019 | 16 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [12] Motion for Shannon K. Clark to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 17 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [13] Motion for Laura K. Fishwick to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 18 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [10] Motion for Susanne Flanders to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 19 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [7] Motion for Nicholas N. Kallas to Appear Pro Hac Vice on behalf of the Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 20 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [9] Motion for Christopher E. Loh to appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 21 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [14] Motion for Gregory J. Manas to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 22 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [8] Motion for Christina Anne Larissa Schwarz to Appear Pro Hac Vice on behalf of the Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 6, 2019 | 23 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [11] Motion for Jared L. Stringham to Appear Pro Hac Vice on behalf of Plaintiff. Signed by Senior Judge Irene M. Keeley on 11/6/19. (mh) |
Nov 5, 2019 | 7 | Text of Proposed Order (1) |
Nov 5, 2019 | 8 | Text of Proposed Order (1) |
Nov 5, 2019 | 9 | Text of Proposed Order (1) |
Nov 5, 2019 | 10 | Text of Proposed Order (1) |
Nov 5, 2019 | 11 | Text of Proposed Order (1) |
Nov 5, 2019 | 12 | Text of Proposed Order (1) |
Nov 5, 2019 | 13 | Text of Proposed Order (1) |
Nov 5, 2019 | 14 | Text of Proposed Order (1) |
Nov 5, 2019 | 7 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Nicholas N. Kallas by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 8 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Christina Anne Larissa Schwarz by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 9 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Christopher E. Loh by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 10 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Susanne Flanders by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 11 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jared L. Stringham by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 12 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Shannon K. Clark by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 13 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Laura K. Fishwick by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Nov 5, 2019 | 14 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Gregory J. Manas by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Text of Proposed Order)(Companion, James) |
Oct 30, 2019 | 1 | Complaint (15) |
Oct 30, 2019 | 1 | Exhibit A - Patent Information (11) |
Oct 30, 2019 | 1 | Exhibit B - Patent Information (11) |
Oct 30, 2019 | 1 | Exhibit C - Patent Information (21) |
Oct 30, 2019 | 1 | Exhibit D - Patent Information (20) |
Oct 30, 2019 | 1 | Civil Cover Sheet (2) |
Oct 30, 2019 | 3 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (dk) |
Oct 30, 2019 | 4 | Other Document (2) Docket Text: Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) filed by Novartis Pharmaceuticals Corporation. (dk) |
Oct 30, 2019 | 5 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (dk) |
Oct 30, 2019 | 6 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION to Attorneys Schwarz, Flanders, Clark, Fishwick, and Manas. (dk) |
Oct 30, 2019 | 1 | Main Document (15) Docket Text: COMPLAINT against All Defendants, filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A - Patent Information, # (2) Exhibit B - Patent Information, # (3) Exhibit C - Patent Information, # (4) Exhibit D - Patent Information, # (5) Civil Cover Sheet)(dk) |
Oct 30, 2019 | 1 | Complaint* (1) |